Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

[Improvement of LDL-C target value achievement through cardiac rehabilitation in patients with acute coronary syndrome: PATIENT-CARE registry].

Schwaab B, Zeymer U, Jannowitz C, Pittrow D, Gitt A.

MMW Fortschr Med. 2019 Jul;161(Suppl 5):21-24. doi: 10.1007/s15006-019-0742-y. Epub 2019 Jul 16. German.

PMID:
31313267
2.

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J.

Respir Res. 2019 Mar 15;20(1):59. doi: 10.1186/s12931-019-1020-3.

3.

Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy.

Neidenbach R, Niwa K, Oto O, Oechslin E, Aboulhosn J, Celermajer D, Schelling J, Pieper L, Sanftenberg L, Oberhoffer R, de Haan F, Weyand M, Achenbach S, Schlensak C, Lossnitzer D, Nagdyman N, von Kodolitsch Y, Kallfelz HC, Pittrow D, Bauer UMM, Ewert P, Meinertz T, Kaemmerer H.

Cardiovasc Diagn Ther. 2018 Dec;8(6):716-724. doi: 10.21037/cdt.2018.10.16. Review.

4.

Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part I: development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia.

Neidenbach R, Niwa K, Oto O, Oechslin E, Aboulhosn J, Celermajer D, Schelling J, Pieper L, Sanftenberg L, Oberhoffer R, de Haan F, Weyand M, Achenbach S, Schlensak C, Lossnitzer D, Nagdyman N, von Kodolitsch Y, Kallfelz HC, Pittrow D, Bauer UMM, Ewert P, Meinertz T, Kaemmerer H.

Cardiovasc Diagn Ther. 2018 Dec;8(6):705-715. doi: 10.21037/cdt.2018.10.15. Review.

5.

Cardiovascular risk algorithms in primary care: Results from the DETECT study.

Grammer TB, Dressel A, Gergei I, Kleber ME, Laufs U, Scharnagl H, Nixdorff U, Klotsche J, Pieper L, Pittrow D, Silber S, Wittchen HU, März W.

Sci Rep. 2019 Jan 31;9(1):1101. doi: 10.1038/s41598-018-37092-7.

6.
7.

Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study.

Kische H, Hoyer J, Pieper L, Venz J, Klotsche J, März W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, Stalla GK, Zeiher AM, Wittchen HU, Haring R.

PLoS One. 2018 Nov 29;13(11):e0207870. doi: 10.1371/journal.pone.0207870. eCollection 2018. No abstract available.

8.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
9.

Risk assessment in pulmonary arterial hypertension.

Hoeper MM, Pittrow D, Opitz C, Gibbs JSR, Rosenkranz S, Grünig E, Olsson KM, Huscher D.

Eur Respir J. 2018 Mar 29;51(3). pii: 1702606. doi: 10.1183/13993003.02606-2017. Print 2018 Mar. No abstract available.

10.

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany.

Kramm T, Wilkens H, Fuge J, Schäfers HJ, Guth S, Wiedenroth CB, Weingard B, Huscher D, Pittrow D, Cebotari S, Hoeper MM, Mayer E, Olsson KM.

Clin Res Cardiol. 2018 Jul;107(7):548-553. doi: 10.1007/s00392-018-1215-5. Epub 2018 Feb 15.

11.

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.

Zelniker TA, Huscher D, Vonk-Noordegraaf A, Ewert R, Lange TJ, Klose H, Dumitrescu D, Halank M, Held M, Gall H, Pittrow D, Hoeper MM, Frankenstein L.

Clin Res Cardiol. 2018 Jun;107(6):460-470. doi: 10.1007/s00392-018-1207-5. Epub 2018 Jan 24.

PMID:
29368137
12.

Longitudinal change instead of baseline testosterone predicts depressive symptoms.

Kische H, Pieper L, Venz J, Klotsche J, März W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, Stalla GK, Zeiher AM, Wittchen HU, Haring R.

Psychoneuroendocrinology. 2018 Mar;89:7-12. doi: 10.1016/j.psyneuen.2017.12.013. Epub 2017 Dec 21.

PMID:
29306775
13.

The role of gender and anxiety in the association between somatic diseases and depression: findings from three combined epidemiological studies in primary care.

Asselmann E, Venz J, Pieper L, Wittchen HU, Pittrow D, Beesdo-Baum K.

Epidemiol Psychiatr Sci. 2019 Jun;28(3):321-332. doi: 10.1017/S2045796017000567. Epub 2017 Nov 9.

PMID:
29117876
14.

Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.

Schmidt N, Schmidt B, Dressel A, Gergei I, Klotsche J, Pieper L, Scharnagl H, Kleber ME, März W, Lehnert H, Pittrow D, Stalla G, Wittchen HU, Grammer TB.

Atherosclerosis. 2017 Nov;266:24-30. doi: 10.1016/j.atherosclerosis.2017.08.019. Epub 2017 Aug 19.

PMID:
28946037
15.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug.

16.

[Atorvastatin therapy under clinical practice conditions - which LDL-C levels are achieved in patients at very high cardiovascular risk?]

Laufs U, Jannowitz C, Pittrow D.

Dtsch Med Wochenschr. 2017 Aug;142(16):1249-1252. doi: 10.1055/s-0042-121868. Epub 2017 Jul 27. German.

PMID:
28750422
17.

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Herth FJF, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Frankenberger M, Behr J.

Respir Res. 2017 Jul 14;18(1):139. doi: 10.1186/s12931-017-0621-y.

18.

Improved risk stratification in prevention by use of a panel of selected circulating microRNAs.

Keller T, Boeckel JN, Groß S, Klotsche J, Palapies L, Leistner D, Pieper L, Stalla GK, Lehnert H, Silber S, Pittrow D, Maerz W, Dörr M, Wittchen HU, Baumeister SE, Völker U, Felix SB, Dimmeler S, Zeiher AM.

Sci Rep. 2017 Jul 3;7(1):4511. doi: 10.1038/s41598-017-04040-w.

19.

Rationale, design, and methodology of the observational INSIGHTS-SVT study on the current state of care and outcomes of patients with superficial vein thrombosis.

Bauersachs R, Gerlach HE, Heinken A, Hoffmann U, Langer F, Noppeney T, Pittrow D, Klotsche J, Rabe E; Collaborators.

J Vasc Surg Venous Lymphat Disord. 2017 Jul;5(4):553-560.e1. doi: 10.1016/j.jvsv.2017.03.013.

PMID:
28623995
20.

Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS study.

Reiser M, Borte M, Huscher D, Baumann U, Pittrow D, Sommer C, Stangel M, Fasshauer M, Gold R, Hensel M.

Eur J Haematol. 2017 Aug;99(2):169-177. doi: 10.1111/ejh.12900. Epub 2017 Jun 21.

PMID:
28467615
21.

[Pilot study of psychiatric and social aspects of children and adolescents with fragile X syndrome].

Häßler F, Gaese F, Colla M, Huss M, Kretschmar C, Brinkman M, Peters H, Elstner S, Weirich S, Pittrow D.

Z Kinder Jugendpsychiatr Psychother. 2017 Mar;45(2):141-147. doi: 10.1024/1422-4917/a000466. Epub 2016 Sep 26. German.

PMID:
28320243
22.

Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study.

Haessler F, Gaese F, Huss M, Kretschmar C, Brinkman M, Peters H, Elstner S, Colla M, Pittrow D.

BMC Psychiatry. 2016 Sep 10;16(1):318. doi: 10.1186/s12888-016-1020-5.

23.

Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

Opitz CF, Hoeper MM, Gibbs JS, Kaemmerer H, Pepke-Zaba J, Coghlan JG, Scelsi L, D'Alto M, Olsson KM, Ulrich S, Scholtz W, Schulz U, Grünig E, Vizza CD, Staehler G, Bruch L, Huscher D, Pittrow D, Rosenkranz S.

J Am Coll Cardiol. 2016 Jul 26;68(4):368-78. doi: 10.1016/j.jacc.2016.05.047.

24.

Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry.

Stangel M, Gold R, Pittrow D, Baumann U, Borte M, Fasshauer M, Hensel M, Huscher D, Reiser M, Sommer C.

Ther Adv Neurol Disord. 2016 May;9(3):165-79. doi: 10.1177/1756285616629869. Epub 2016 Feb 16.

25.

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.

Laufs U, Karmann B, Pittrow D.

Clin Res Cardiol. 2016 Sep;105(9):783-90. doi: 10.1007/s00392-016-0991-z. Epub 2016 Apr 27.

26.

Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry.

Kistner I, Zeymer U, Dechend R, Hagedorn I, Riemer T, Bramlage P, Pittrow D, Senges J, Schmieder RE.

J Clin Hypertens (Greenwich). 2016 Oct;18(10):1045-1053. doi: 10.1111/jch.12828. Epub 2016 Apr 20.

27.

Usefulness of Direct Oral Anticoagulants in Adult Congenital Heart Disease.

Pujol C, Niesert AC, Engelhardt A, Schoen P, Kusmenkov E, Pittrow D, Ewert P, Kaemmerer H.

Am J Cardiol. 2016 Feb 1;117(3):450-5. doi: 10.1016/j.amjcard.2015.10.062. Epub 2015 Nov 18.

PMID:
26725103
28.

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.

Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, Lange TJ, Claussen M, Grohé C, Klose H, Olsson KM, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs JS.

PLoS One. 2015 Dec 2;10(12):e0141911. doi: 10.1371/journal.pone.0141911. eCollection 2015.

29.

Incidence and prevalence of pulmonary arterial hypertension in Germany.

Hoeper MM, Huscher D, Pittrow D.

Int J Cardiol. 2016 Jan 15;203:612-3. doi: 10.1016/j.ijcard.2015.11.001. Epub 2015 Nov 9. No abstract available.

PMID:
26580339
30.

Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany.

Gitt AK, Sonntag F, Jannowitz C, Weizel A, Karmann B, Schaefer JR, Pittrow D, Hildemann SK.

Curr Med Res Opin. 2016;32(3):417-26. doi: 10.1185/03007995.2015.1120715. Epub 2015 Dec 29.

PMID:
26568400
31.

Two-Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non-Interventional Prospective Study.

Zeymer U, Dechend R, Riemer T, Deeg E, Senges J, Pittrow D, Schmieder R; 3A Registry Investigators.

J Clin Hypertens (Greenwich). 2016 Jul;18(7):647-54. doi: 10.1111/jch.12725. Epub 2015 Nov 14.

32.

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D.

Eur Respir J. 2015 Jul;46(1):186-96. doi: 10.1183/09031936.00217614. Epub 2015 Apr 2.

33.

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.

Goette A, Benninger G, Pittrow D, Paar WD, von Stritzky B, Bosch RF.

Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):148-54. doi: 10.1007/s00399-015-0360-z. Epub 2015 Mar 8.

34.

[Psychiatric and Social Aspects of Patients with Fragile X Syndrome].

Pittrow D, Gaese F, Colla M, Huss M, Kretschmar C, Brinkman M, Peters H, Elstner S, Weirich S, Häßler F.

Psychiatr Prax. 2016 Apr;43(3):160-4. doi: 10.1055/s-0034-1387517. Epub 2015 Feb 2. German.

PMID:
25643039
35.

Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry.

Behr J, Hoeper MM, Kreuter M, Klotsche J, Wirtz H, Pittrow D.

BMJ Open Respir Res. 2014 Jan 3;1(1):e000010. doi: 10.1136/bmjresp-2013-000010. eCollection 2014. Erratum in: BMJ Open Respir Res. 2014;1(1):e000010corr1.

36.

Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry.

Pittrow D, Klotsche J, Kreuter M, Hoeper MM, Wirtz H, Koschel D, Claussen M, Andreas S, Grohé C, Geier S, Koppe U, Behr J.

Value Health. 2014 Nov;17(7):A600. doi: 10.1016/j.jval.2014.08.2078. Epub 2014 Oct 26. No abstract available.

37.

Current Situation of Paediatric and Adult Patients With Fragile X Syndrome: Preliminary Data From the Explain Fxs Registry.

Haessler F, Gaese F, Pittrow D, Huss M, Peters H, Kretschmar C, Brinkman M, Elstner S, Colla M.

Value Health. 2014 Nov;17(7):A505. doi: 10.1016/j.jval.2014.08.1533. Epub 2014 Oct 26. No abstract available.

38.

Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry.

Brüggenjürgen B, Schliephacke T, Darius H, De Caterina R, Le Heuzey JY, Pittrow D, Reimitz PE, Schilling RJ, Zamorano JL, Kirchhof P.

Value Health. 2014 Nov;17(7):A473. doi: 10.1016/j.jval.2014.08.1346. Epub 2014 Oct 26. No abstract available.

39.

Management and outcomes of patients with reduced ejection fraction after acute myocardial infarction in cardiac rehabilitation centers.

Reibis R, Jannowitz C, Halle M, Pittrow D, Gitt A, Völler H.

Curr Med Res Opin. 2015 Feb;31(2):211-9. doi: 10.1185/03007995.2014.977854. Epub 2014 Oct 29.

PMID:
25325219
40.

1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: prospective 3A registry.

Zeymer U, Dechend R, Riemer T, Kaiser E, Senges J, Pittrow D, Schmieder RE; 3A Registry Investigators.

Int J Cardiol. 2014 Oct 20;176(3):589-94. doi: 10.1016/j.ijcard.2014.07.089. Epub 2014 Aug 1.

PMID:
25305705
41.

The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.

Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, Pittrow D, Senges J, Schmieder RE.

J Hum Hypertens. 2015 May;29(5):316-23. doi: 10.1038/jhh.2014.86. Epub 2014 Oct 2.

PMID:
25273857
42.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

PMID:
25223780
43.

Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries.

Schweikert B, Pittrow D, Vizza CD, Pepke-Zaba J, Hoeper MM, Gabriel A, Berg J, Sikirica M.

BMC Health Serv Res. 2014 Jun 9;14:246. doi: 10.1186/1472-6963-14-246.

44.

Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers.

Reibis R, Völler H, Gitt A, Jannowitz C, Halle M, Pittrow D, Hildemann S.

Clin Cardiol. 2014 Apr;37(4):213-21.

45.

Management of patients with atrial fibrillation by primary-care physicians in Germany: 1-year results of the ATRIUM registry.

Kirchhof P, Schmalowsky J, Pittrow D, Rosin L, Kirch W, Wegscheider K, Meinertz T; ATRIUM Study Group.

Clin Cardiol. 2014 May;37(5):277-84. doi: 10.1002/clc.22272. Epub 2014 Mar 20.

46.

Improved detection of paroxysmal atrial fibrillation utilizing a software-assisted electrocardiogram approach.

Schaefer JR, Leussler D, Rosin L, Pittrow D, Hepp T.

PLoS One. 2014 Feb 28;9(2):e89328. doi: 10.1371/journal.pone.0089328. eCollection 2014.

47.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.

Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR; CTD-ILD Special Interest Group.

Thorax. 2014 May;69(5):428-36. doi: 10.1136/thoraxjnl-2013-204202. Epub 2013 Dec 24. Erratum in: Thorax. 2014 Sep;69(9):834. CTD-ILD Special Interest Group [added]; multiple investigator names added.

48.

EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X Syndrome.

Haessler F, Gaese F, Colla M, Huss M, Kretschmar C, Brinkman M, Schieb H, Peters H, Elstner S, Pittrow D.

BMC Psychiatry. 2013 Dec 19;13:339. doi: 10.1186/1471-244X-13-339.

49.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Jan 7;129(1):57-65. doi: 10.1161/CIRCULATIONAHA.113.004526. Epub 2013 Sep 30.

PMID:
24081973
50.

Gender differences in patients with atrial fibrillation.

Bosch RF, Pittrow D, Beltzer A, Kruck I, Kirch W, Kohlhaussen A, Bonnemeier H.

Herzschrittmacherther Elektrophysiol. 2013 Sep;24(3):176-83. doi: 10.1007/s00399-013-0283-5. Epub 2013 Aug 27.

PMID:
23979564

Supplemental Content

Loading ...
Support Center